Oura and Counsel Partner with CMS ACCESS Model to Bring AI-Native Chronic Care to Medicare Beneficiaries Using Continuous Biometric Data

The landscape of modern healthcare is undergoing a profound structural shift, characterized by the convergence of consumer wearable technology, advanced artificial intelligence, and value-based clinical care models. In a significant development that bridges the gap between everyday wellness tracking and institutional healthcare delivery, smart-ring pioneer Oura announced a major expansion of its strategic partnership with AI-native primary care provider Counsel. This collaboration is designed to participate in the Centers for Medicare & Medicaid Services (CMS) Innovation Center’s newly established Advancing Chronic Care with Effective Scalable Solutions (ACCESS) Model.

Set to officially roll out in early 2027, this federal initiative will enable Counsel to deliver specialized, AI-enhanced chronic care management at absolutely no out-of-pocket cost to eligible Medicare beneficiaries. The program spans nearly all United States jurisdictions and targets some of the nation’s most prevalent and resource-intensive chronic health conditions: hypertension, obesity, hyperlipidemia, and prediabetes. By leveraging the continuous physiological data captured by the Oura Ring alongside Counsel’s proprietary medical artificial intelligence and board-certified physician network, the partnership aims to construct a scalable framework that transforms passive health monitoring into proactive, clinician-led intervention for older Americans.

The Evolution of the Oura and Counsel Partnership

To understand the magnitude of the ACCESS Model integration, one must examine the trajectory of the collaboration between Oura and Counsel, which first captured industry attention in May. The initial alliance was forged out of a shared recognition that consumer health technology often provides individuals with a wealth of biometric insights—such as resting heart rate, heart rate variability, body temperature trends, and sleep architecture—while leaving a critical void when it comes to actionable clinical guidance.

For months, the partnership has allowed Oura members to seamlessly transition from viewing daily health metrics within the Oura App to receiving direct, on-demand clinical actions from Counsel’s multidisciplinary team. This bridge between personal health data and professional medical interpretation proved immediately popular among users. Early metrics from the collaboration indicate a high degree of patient satisfaction; members who utilized Counsel’s physician services following data prompts rated their clinical interactions an impressive 4.6 out of 5 stars. Users frequently praised the service for demystifying complex trends in their biometric data and offering clear, structured pathways for what steps to take next.

Building upon this successful foundation, the inclusion in the CMS ACCESS Model represents a natural yet monumental evolution. Rather than operating purely as a direct-to-consumer wellness integration, the partnership will now scale its proven methodology to meet the complex medical needs of the Medicare population, operating under the rigorous oversight and evaluation framework of federal healthcare innovation standards.

Decoding the CMS ACCESS Model and Clinical Scope

The CMS Innovation Center, officially known as the Center for Medicare and Medicaid Innovation (CMMI), was established under the Affordable Care Act to test innovative payment and service delivery models designed to reduce program expenditures while preserving or enhancing the quality of care. The Advancing Chronic Care with Effective Scalable Solutions (ACCESS) Model is the latest federal effort to tackle the escalating burden of chronic disease in an aging demographic.

Chronic conditions remain the primary driver of healthcare utilization and expenditure in the United States, accounting for the vast majority of Medicare spending. Conditions such as hypertension and obesity are foundational risk factors for more severe cardiovascular events, kidney disease, and metabolic disorders. Traditional fee-for-service primary care structures often struggle to manage these ongoing conditions effectively, as they are typically reactive rather than proactive, relying on sporadic in-person office visits that fail to capture the day-to-day fluctuations of a patient’s health status.

Under the terms of the ACCESS Model partnership, Counsel’s platform will act as a centralized hub for continuous chronic disease management. By combining the processing power of artificial intelligence with human clinical expertise, Counsel can monitor patient data streams continuously, identify early warning signs or negative trends, and initiate outreach or treatment adjustments before minor physiological shifts escalate into acute medical emergencies. Crucially, the removal of financial barriers—offering these services at zero out-of-pocket cost to eligible beneficiaries—addresses equity concerns, ensuring that low- and fixed-income older adults have access to cutting-edge digital health interventions.

Demographics and the Oura Member Ecosystem

A critical driver behind this partnership is the changing demographic profile of Oura’s user base. Historically, the smart wearable market was perceived as being dominated by younger, tech-savvy demographics focused on athletic performance and fitness optimization. However, market adoption has shifted dramatically in recent years. Today, individuals aged 65 and older represent one of Oura’s most highly engaged and active user cohorts, demonstrating remarkable consistency in daily app engagement and health tracking habits.

This high level of engagement among older adults provides a unique infrastructural advantage for deploying health initiatives. Furthermore, internal data underscores the acute medical relevance of this demographic segment for the targeted conditions: approximately 20% of Oura members aged 65 and older present with a Body Mass Index (BMI) of 30 or higher, placing them in the clinical category for obesity and elevating their risk profile for cardio-kidney-metabolic disorders.

The integration of Oura’s continuous physiological tracking with Counsel’s medical infrastructure creates a closed-loop system tailored to this high-risk population. While episodic clinical visits capture isolated snapshots of blood pressure, weight, or metabolic markers, the Oura Ring supplies an unbroken stream of contextual data regarding sleep quality, autonomic nervous system recovery, and nocturnal physiological stress. When analyzed in aggregate, this continuous data stream enables physicians to formulate hyper-personalized care plans that reflect the patient’s actual daily lived experience rather than idealized clinical environments.

Official Perspectives and Strategic Vision

Leadership from both organizations have emphasized the transformative potential of blending consumer hardware intelligence with institutional healthcare delivery.

"Earlier in the year, we partnered with Counsel to help Oura Members move from health insights to clinical action," stated Dr. Ricky Bloomfield, Chief Medical Officer at Oura. "The ACCESS program gives us the opportunity to study that model at scale, and to better understand how continuous biometric data, combined with physician-led care, can support Medicare beneficiaries managing hypertension, obesity, and other early cardio-kidney-metabolic conditions."

Dr. Bloomfield’s remarks highlight the dual purpose of the initiative: providing immediate, high-quality care to patients while simultaneously generating rigorous, scalable data that could inform future healthcare policy and reimbursement models nationwide. By demonstrating that continuous biometric monitoring can drive positive clinical outcomes and lower overall costs within the Medicare program, Oura and Counsel hope to establish a new benchmark for digital health integration.

Logistics, Eligibility, and the Path to 2027

As the healthcare industry looks ahead to the official launch in early 2027, both companies are laying the groundwork for seamless onboarding and operational execution. The enrollment process has been designed to be user-friendly while maintaining strict clinical standards.

Oura will act as an informational conduit within the digital ecosystem of the Oura App, identifying interested members who fit the target profile and connecting them directly with Counsel. However, to maintain regulatory compliance and clinical integrity, Counsel will maintain full autonomy over the intake process. Counsel’s clinical team will independently verify patient eligibility according to CMS criteria, manage formal enrollment, and oversee all aspects of patient care delivery.

Comprehensive details regarding specific eligibility requirements, geographic rollouts within U.S. states, and step-by-step instructions for how qualifying Oura members can enroll through the mobile application will be released by the companies as the 2027 launch date approaches.

Broader Implications for the Digital Health Landscape

The collaboration between Oura and Counsel within the CMS ACCESS Model signals a broader maturation of the digital health sector. For over a decade, consumer wellness devices and clinical medicine existed in largely separate silos, hampered by regulatory hurdles, data interoperability challenges, and skepticism from traditional healthcare providers regarding the medical utility of consumer-grade hardware.

Initiatives like the ACCESS Model demonstrate that federal regulators are increasingly recognizing the value of continuous, patient-generated health data in managing chronic disease. By validating this model through a major federal program, CMS is signaling a willingness to embrace AI-native care delivery and wearable technology as legitimate, scalable components of the national healthcare infrastructure.

If successful, this partnership could serve as a blueprint for future collaborations between technology companies and the federal health system. It proves that consumer devices can evolve beyond simple lifestyle accessories to become vital instruments in clinical diagnostics and chronic disease management. For the millions of Medicare beneficiaries grappling with hypertension, obesity, and metabolic conditions, the convergence of Oura’s continuous monitoring and Counsel’s AI-driven physician care promises a future where healthcare is not only more accessible and affordable, but fundamentally more personalized, continuous, and proactive.